Investments (Tables)

12 Months Ended

Dec. 31, 2021

Equity Method Investments and Joint Ventures [Abstract]

Equity Method Investments

The Company used the following summarized financial information for NantOmics for the trailing twelve months ended September 30, 2020 to record its equity investment method losses, as applicable, for the year ended December 31, 2020.

	Twelve Months Ended September 30, 2020
Revenues	$	349
Gross loss	(1,641)
Loss from operations	(7,806)
Impairments on equity investments	—
Net loss	(2,618)
Net loss attributable to NantOmics	(2,559)
Other comprehensive income	—